Nwata na-ehi ụra n'okpuru aụgbụ anwụnta.N'ime nnyocha e mere n'oge na-adịbeghị anya, ụgbụ ejiri clofenapyr mee ka ọrịa ịba belata site na 43% n'afọ mbụ na 37% n'afọ nke abụọ ma e jiri ya tụnyere ọkọlọtọ pyrethroid-naanị ụgbụ. Foto |Akwụkwọ
Ụdị ụgbụ akwa ọhụrụ nke nwere ike ime ka anwụnta na-eguzogide ọgwụ ụmụ ahụhụ ọdịnala belatara nke ukwuu ọrịa ịba na Tanzania, ndị ọkà mmụta sayensị kwuru.
E jiri ya tụnyere ụgbụ pyrethroid nkịtị, ụgbụ ahụ belatara nke ukwuu ịba ụba nke ịba, belata ọnụ ọgụgụ ọrịa ụmụaka site na ihe fọrọ nke nta ka ọ bụrụ ọkara ma belata usoro ọgwụgwọ ọrịa ahụ site na pasent 44 n'ime afọ abụọ nke nnwale ya.
N'adịghị ka ụmụ ahụhụ na-egbu anwụnta, ụgbụ ọhụrụ ahụ na-eme ka anwụnta ghara ịchebe onwe ya, ịkwaga ma ọ bụ taa, agụụ na-agụ ha, dịka nchọpụta e bipụtara na March na Lancet.
N'ime ọmụmụ ihe a gụnyere ihe karịrị ezinụlọ 39,000 na ihe karịrị ụmụaka 4,500 na Tanzania, a chọpụtara na ụgbụ ụmụ ahụhụ na-adịte aka ejiri ọgwụ ụmụ ahụhụ abụọ, chlorfenapyr na chlorfenapyr LLIN, belata ịba ụba nke ịba site na 43% ma e jiri ya tụnyere ọkọlọtọ pyrethroid naanị ụgbụ. , na mbelata nke abụọ nke 37%.
Nnyocha ahụ chọpụtara na clofenapyr belatara ọnụ ọgụgụ anwụnta nke ịba na-ebute site na pasent 85.
Dị ka ndị ọkà mmụta sayensị si kwuo, clofenapyr na-eme ihe dị iche iche karịa pyrethroids site n'ime ka spasms na akwara pterygoid, nke na-egbochi ọrụ nke akwara ụgbọ elu.
Dr. Manisha Kulkarni, bụ́ prọfesọ osote na Mahadum Ottawa's School of Epidemiology, kwuru, sị: “Ọrụ anyị ịgbakwụnye clofenac na ụgbụ pyrethroid ọkọlọtọ nwere ikike dị ukwuu iji chịkwaa ịba nke anwụnta na-eguzogide ọgwụ na-ebufe n'Africa site n'isi 'ikwasa' anwụnta." Ahụike Ọha.
N'ụzọ dị iche, ụgbụ akwa ejiri piperonyl butoxide (PBO) agwọta iji kwalite nrụpụta pyrethroids belatara ọrịa ịba site na 27% n'ime ọnwa iri na abụọ mbụ nke nnwale ahụ, mana mgbe afọ abụọ gachara site na iji ụgbụ ọkọlọtọ.
Ụgbụ nke atọ a na-emeso ya na pyrethroid na pyriproxyfen (ụnwụ anwụnta ndị inyom na-adịghị agwụ agwụ) nwere ntakịrị mmetụta ọzọ ma e jiri ya tụnyere ụgbụ pyrethroid ọkọlọtọ. Ihe kpatara ya abụghị ihe doro anya kpamkpam, ma ọ nwere ike ịbụ n'ihi na pyriproxyfen ezughi oke na-anọ na ntanetị n'oge.
"N'agbanyeghị na ọ dị oke ọnụ, ọnụ ahịa dị elu nke clofenazim LLIN na-akwụ ụgwọ site na nchekwa ego site na ibelata ọnụ ọgụgụ ọrịa ịba na-achọ ọgwụgwọ.Ya mere, ezinụlọ na ọha na eze na-ekesa ụgbụ clofenazim yikarịrị ka ọnụ ahịa a na-atụ anya na ọ ga-adị ala, "otu ndị ọkà mmụta sayensị kwuru, bụ ndị nwere olileanya na Òtù Ahụ Ike Ụwa na mmemme nchịkwa ịba ga-anabata ụgbụ ọhụrụ ahụ na mpaghara ndị na-eguzogide ọgwụ ahụhụ. anwụnta.
Nchọpụta sitere na National Institute of Medicine, Kilimanjaro Christian University College of Medicine, London School of Hygiene and Tropical Medicine (LSHTM) na Mahadum Ottawa bụ ozi nnabata na kọntinent ebe ụgbụ akwa akwa na-ada obere ichebe ndị mmadụ pụọ na nje nje.
Ụgbụ akwa a na-agwọ ụmụ ahụhụ nyere aka igbochi 68% nke ọrịa ịba na Sub Saharan Africa n'etiti 2000 na 2015. N'ime afọ ole na ole gara aga, agbanyeghị, mbelata nke ọnụọgụ ịba akwụsịla ma ọ bụ ọbụna gbanwee na mba ụfọdụ.
Mmadụ 627,000 nwụrụ n'ihi ịba na 2020, ma e jiri ya tụnyere 409,000 na 2019, ọkachasị n'Africa na ụmụaka.
"Nsonaazụ ndị a na-akpali akpali na-egosi na anyị nwere ngwá ọrụ ọzọ dị irè iji nyere aka ịchịkwa ịba," ka onye nduzi ọmụmụ, Dr Jacklin Mosha si Tanzania National Institute of Medical Research kwuru.
"Ụgbụ anwụnta na-adịghị efe efe, nke na-adịghị ata ahụhụ," nke a na-erere dị ka "Interceptor® G2," nwere ike iduga nnukwu uru nchịkwa ịba na Sub Saharan Africa, otu ahụ kwuru.
Otú ọ dị, ha na-ekwu na ọ dị mkpa nyocha ọzọ iji nwalee ihe ga-ekwe omume nke ịbawanye elu na ịtụ aro usoro njikwa nguzogide dị mkpa iji nọgide na-arụ ọrụ n'ime ogologo oge.
“Achọrọ ịkpachara anya,” ka onye na-ede akwụkwọ na-adọ aka ná ntị, Natacha Protopopoff.” Mmụbawanye nke ọkọlọtọ pyrethroid LLIN afọ 10 ruo 20 gara aga butere mgbasa ngwa ngwa nke nguzogide pyrethroid.Ihe ịma aka ugbu a bụ ịnọgide na-arụ ọrụ nke clofenazepam site n'ịmepụta usoro njikwa nguzogide ezi uche. "
Nke a bụ nke mbụ n'ime ọtụtụ ule a na-eji ụgbụ anwụnta clofenapyr. Ndị ọzọ nọ na Benin, Ghana, Burkina Faso na Côte d'Ivoire.
Mpaghara ala kpọrọ nkụ na nke kpọrọ nkụ bụ ihe kacha emetụta, ebe ihe ọkụkụ nke mba ahụ gbadara pasenti 70.
Oge nzipu: Eprel-12-2022